(VIANEWS) – KENDRION (KENDR.AS), TIKEHAU CAPITAL (TKO.PA), VALNEVA (VLA.PA) have the highest dividend yield stocks on this list.
Financial Asset | Forward Dividend Yield | Updated (EST) |
---|---|---|
KENDRION (KENDR.AS) | 6.12% | 2023-12-22 08:02:42 |
TIKEHAU CAPITAL (TKO.PA) | 3.6% | 2023-12-22 09:23:44 |
VALNEVA (VLA.PA) | 3.35% | 2023-12-22 09:24:12 |
TIPIAK (TIPI.PA) | 2.48% | 2023-12-17 08:01:28 |
CEGEDIM (CGM.PA) | 2.25% | 2023-12-22 09:01:00 |
Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. KENDRION (KENDR.AS)
6.12% Foward Dividend Yield
KENDRION’s last close was €11.84, 39.59% below its 52-week high of €19.60. Intraday change was 0.17%.
Kendrion N.V. develops, manufactures, and markets electromagnetic systems and components for industrial and automotive applications in Germany, rest of Europe, the Americas, Asia, and internationally. The company operates in two segments, Industrial and Automotive. It offers linear, locking, oscillating, rotary, and park lock solenoids, as well as solenoids and valves for electronically controlled dampers; holding and permanent magnets; actuators; door lock systems; optical beam shutters; solenoid pinch valves; permanent magnet, spring-applied, and electromagnetic brakes; electronic modules and rectifiers; service and spare parts; shutting-speed regulators; customer solutions; electromagnetic clutches, clutch brake units, magnetic particle and pneumatic clutches and brakes, A/C clutches, auxiliary drive clutches, and clutches for hybrid drive; and belt-drive and engine-cooling systems. The company also provides electronic assemblies for actuators; HMI devices, I/O systems, control and heating systems, starterkits, and programming tools and applications for control, visualisation, motion, copy protection, and remote service; electronic control units for electric motors and inductive loads; automotive sensors and pressure switches; vehicle sound systems; direct and pilot operated solenoid, fluid isolation, proportional, and miniature valves, as well as manually, mechanically, and pneumatically actuated valves; pneumatic timers; and valve blocks. In addition, it offers pressure regulators, sensor cleaning solutions, park lock valves, valves for multichamber air-springs, internal combustion engines, seating comfort products, and mobile hydraulics. The company was formerly known as Schuttersveld N.V. and changed its name to Kendrion N.V. in 2001. Kendrion N.V. was founded in 1859 and is headquartered in Amsterdam, the Netherlands.
Earnings Per Share
As for profitability, KENDRION has a trailing twelve months EPS of €-3.24.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -23.11%.
More news about KENDRION.
2. TIKEHAU CAPITAL (TKO.PA)
3.6% Foward Dividend Yield
TIKEHAU CAPITAL’s last close was €20.50, 24.07% under its 52-week high of €27.00. Intraday change was 2.22%.
Tikehau Capital is a private equity and venture capital firm specializing in providing a full range of financing products including senior secured loans, equity, senior debt, unitranche, mezzanine, and preferred shares. The firm seeks to make early stage, mezzanine, and turnaround investments and manage long-term capital for institutional and private investors in various asset classes including credit, listed, private equity, and real estate. It invests in all sectors and all countries with a focus on Singapore. The firm prefers to invest between €0.41 million ($0.5 million) and €70 million ($82.1073 million). The firm seeks to invest in small and middle market European corporate. It makes balance sheet investments. Tikehau Capital was founded in June 2004 and is based in Paris, France with additional offices across Middle East, Europe, North America and Asia.
Earnings Per Share
As for profitability, TIKEHAU CAPITAL has a trailing twelve months EPS of €0.64.
PE Ratio
TIKEHAU CAPITAL has a trailing twelve months price to earnings ratio of 32.34. Meaning, the purchaser of the share is investing €32.34 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.68%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 41.6%, now sitting on 428.12M for the twelve trailing months.
Yearly Top and Bottom Value
TIKEHAU CAPITAL’s stock is valued at €20.70 at 11:50 EST, way under its 52-week high of €27.00 and way higher than its 52-week low of €18.74.
More news about TIKEHAU CAPITAL.
3. VALNEVA (VLA.PA)
3.35% Foward Dividend Yield
VALNEVA’s last close was €4.55, 42.01% under its 52-week high of €7.85. Intraday change was -0.64%.
Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; and VLA2001, an inactivated whole-virus COVID-19 vaccine. The company also develops VLA15, a vaccine candidate, which is in Phase III clinical trial against Borrelia, the bacterium that causes Lyme disease; VLA1553, a vaccine candidate, which is in Phase III clinical trial against the chikungunya virus; VLA1554, a vaccine candidate targeting human metapneumovirus; and VLA2112, a vaccine candidate to treat patients with epstein-barr virus. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, France, rest of European countries, and internationally. Valneva SE has collaborations with Pfizer, Inc. to co-develop and commercialize its Lyme disease vaccine; and Instituto Butantan for the development, manufacturing, and marketing of single-shot chikungunya vaccine. The company was founded in 1998 and is based in Saint-Herblain, France.
Earnings Per Share
As for profitability, VALNEVA has a trailing twelve months EPS of €-0.82.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.81%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 119.7% and positive 259.4% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
VALNEVA’s EBITDA is -49.11.
More news about VALNEVA.
4. TIPIAK (TIPI.PA)
2.48% Foward Dividend Yield
TIPIAK’s last close was €85.50, 22.14% above its 52-week high of €70.00. Intraday change was 0%.
Tipiak Société Anonyme, a food company, manufactures prepared food products, frozen ready-meals, pastry products, groceries, and crusty bread products. The company offers groceries, such as breadcrumbs, cereals, couscous, croutons, Japanese pearls, potato starch, quinoa, and tapioca; frozen products, including savory products, appetizers, and side dishes with grains; and frozen sweet products comprising macarons, mini eclairs, and petits fours. It sells its products in France, England, and the United States. The company was founded in 1830 and is based in Saint-Aignan-Grandlieu, France.
Earnings Per Share
As for profitability, TIPIAK has a trailing twelve months EPS of €1.85.
PE Ratio
TIPIAK has a trailing twelve months price to earnings ratio of 46.22. Meaning, the purchaser of the share is investing €46.22 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.88%.
Volume
Today’s last reported volume for TIPIAK is 74 which is 71.09% below its average volume of 256.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jul 4, 2023, the estimated forward annual dividend rate is 1.65 and the estimated forward annual dividend yield is 2.48%.
Yearly Top and Bottom Value
TIPIAK’s stock is valued at €85.50 at 11:50 EST, way higher than its 52-week high of €70.00.
Moving Average
TIPIAK’s worth is way higher than its 50-day moving average of €65.25 and way above its 200-day moving average of €60.49.
More news about TIPIAK.
5. CEGEDIM (CGM.PA)
2.25% Foward Dividend Yield
CEGEDIM’s last close was €17.90, 23.99% under its 52-week high of €23.55. Intraday change was -0.56%.
Cegedim SA operates as a technology and services company in the field of digital data flow management for healthcare ecosystem and B2B, and business software publisher for healthcare and insurance professionals in France, other European countries, and internationally. It operates in two segments, Health Insurance, HR and e-Services; and Healthcare Professionals. The Health Insurance, HR and e-Services segment markets various products and services to insurance companies, mutual insurers, personal protection insurers, and insurance brokers, as well as engages in the interactions between these entities and healthcare professionals. This segment also provides solutions for hosting, HR and payroll management outsourcing, electronic data exchange, and data processing services. The Healthcare Professionals division sells management software, databases, and solutions to doctors, allied health professionals, pharmacists, and healthcare facilities. The company was incorporated in 1969 and is headquartered in Boulogne-Billancourt, France. Cegedim SA is a subsidiary of FCB SA.
Earnings Per Share
As for profitability, CEGEDIM has a trailing twelve months EPS of €0.8.
PE Ratio
CEGEDIM has a trailing twelve months price to earnings ratio of 22.25. Meaning, the purchaser of the share is investing €22.25 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.08%.
Moving Average
CEGEDIM’s value is below its 50-day moving average of €18.21 and under its 200-day moving average of €19.37.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.5%, now sitting on 588.66M for the twelve trailing months.
More news about CEGEDIM.